KALV vs. ^GSPC
Compare and contrast key facts about KalVista Pharmaceuticals, Inc. (KALV) and S&P 500 (^GSPC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: KALV or ^GSPC.
Correlation
The correlation between KALV and ^GSPC is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
KALV vs. ^GSPC - Performance Comparison
Key characteristics
KALV:
-0.53
^GSPC:
1.77
KALV:
-0.53
^GSPC:
2.39
KALV:
0.94
^GSPC:
1.32
KALV:
-0.34
^GSPC:
2.66
KALV:
-1.16
^GSPC:
10.85
KALV:
27.59%
^GSPC:
2.08%
KALV:
60.64%
^GSPC:
12.79%
KALV:
-96.68%
^GSPC:
-56.78%
KALV:
-92.27%
^GSPC:
0.00%
Returns By Period
In the year-to-date period, KALV achieves a 15.47% return, which is significantly higher than ^GSPC's 4.22% return.
KALV
15.47%
17.83%
-21.85%
-34.19%
-7.15%
N/A
^GSPC
4.22%
2.22%
9.51%
22.46%
12.74%
11.29%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
KALV vs. ^GSPC — Risk-Adjusted Performance Rank
KALV
^GSPC
KALV vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for KalVista Pharmaceuticals, Inc. (KALV) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Drawdowns
KALV vs. ^GSPC - Drawdown Comparison
The maximum KALV drawdown since its inception was -96.68%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for KALV and ^GSPC. For additional features, visit the drawdowns tool.
Volatility
KALV vs. ^GSPC - Volatility Comparison
KalVista Pharmaceuticals, Inc. (KALV) has a higher volatility of 11.23% compared to S&P 500 (^GSPC) at 3.19%. This indicates that KALV's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.